Venture&Growth
Acacia Pharma
Belgian Therapeutics company commercializing supportive care products to treat side effects of medical procedures.
Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Evotec is a drug discovery alliance. It is focused on rapidly developing innovative drugs and other products with leading pharmaceutical and biotechnology companies. Its partners include Bayer, Boehringer Ingelheim, Genentech and Janssen Pharmaceuticals. In addition, Evotec has product candidates both in clinical and pre-clinical development.
Gilde obtained listed Evotec shares (Frankfurt Stock Exchange: EVT) in 2007 after Evotec acquired the French company Neuro3D for its clinical program in schizophrenia.
Venture&Growth
SpliceBio
SpliceBio is a Spanish therapeutics company addressing the key limitations of current gene therapy. It harnesses its proprietary Protein Splicing platform to develop next-generation gene therapies, based on engineered inteins pioneered at the Muir Lab at Princeton University. The company
Venture&Growth
Argá Medtech
Argá Medtech is developing the next generation non-thermal cardiac ablation system. The system for treating atrial fibrillation (AF) uses pulsed field ablation, the energy modality of choice because of a superior safety profile. Arga has a novel catheter design and unique
